Clinician- and Patient-Reported Outcomes With Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin 2023, 7 (3), 771-787. https://doi.org/10.25251/skin.7.3.3.